Phase I/II study of BNC105P in combination with everolimus or following everolimus for progressive metastatic renal cell carcinoma following prior tyrosine kinase inhibitors.
T. E. Hutson
No relevant relationships to disclose
J. Sarantopoulos
No relevant relationships to disclose
T. Logan
No relevant relationships to disclose
G. Sonpavde
No relevant relationships to disclose
M. D. Galsky
No relevant relationships to disclose
C. Sweeney
Consultant or Advisory Role - Bionomics
D. C. Bibby
Employment or Leadership Position - Bionomics
Stock Ownership - Bionomics
G. Kremmidiotis
Employment or Leadership Position - Bionomics
Stock Ownership - Bionomics
E. E. Doolin
Employment or Leadership Position - Bionomics
N. M. Hahn
No relevant relationships to disclose